ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,431 | +9.8% | 517 | +42.0% | 0.00% | – |
| Q2 2023 | $16,792 | +459.7% | 364 | +506.7% | 0.00% | – |
| Q4 2018 | $3,000 | – | 60 | +566.7% | 0.00% | – |
| Q3 2016 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 9 | -97.1% | 0.00% | – |
| Q1 2016 | $19,000 | -13.6% | 311 | +55.5% | 0.00% | -100.0% |
| Q4 2015 | $22,000 | -4.3% | 200 | -14.5% | 0.00% | 0.0% |
| Q3 2015 | $23,000 | -39.5% | 234 | -37.8% | 0.00% | 0.0% |
| Q2 2015 | $38,000 | +100.0% | 376 | +20.9% | 0.00% | – |
| Q1 2015 | $19,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |